Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Times Interest Earned (2017 - 2022)

Sutro Biopharma's Times Interest Earned history spans 6 years, with the latest figure at -$7.61 for Q3 2022.

  • For Q3 2022, Times Interest Earned rose 82.01% year-over-year to -$7.61; the TTM value through Jun 2023 reached -$56.98, down 19.22%, while the annual FY2021 figure was -$31.41, 80.2% down from the prior year.
  • Times Interest Earned for Q3 2022 was -$7.61 at Sutro Biopharma, up from -$32.62 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $23.84 in Q2 2018 and bottomed at -$59.56 in Q1 2022.
  • The 5-year median for Times Interest Earned is -$12.3 (2019), against an average of -$17.14.
  • The largest annual shift saw Times Interest Earned soared 161.0% in 2020 before it crashed 822.81% in 2021.
  • A 5-year view of Times Interest Earned shows it stood at $5.05 in 2018, then plummeted by 458.55% to -$18.09 in 2019, then surged by 161.0% to $11.04 in 2020, then tumbled by 618.72% to -$57.25 in 2021, then soared by 86.71% to -$7.61 in 2022.
  • Per Business Quant, the three most recent readings for STRO's Times Interest Earned are -$7.61 (Q3 2022), -$32.62 (Q2 2022), and -$59.56 (Q1 2022).